Cabergoline Tablet: How It Works, Side Effects and Precautions
Written by Medicover Team and Medically Reviewed by Dr Banam Sravanthi, Gynecology
Cabergoline is a potent dopamine receptor agonist that serves as a first-line treatment for hyperprolactinemia, a condition marked by abnormally high prolactin levels. By targeting the root cause of excessive prolactin secretion, this medication effectively restores hormonal balance, alleviating symptoms like irregular menstruation, infertility, and lactation abnormalities.
With superior efficacy compared to alternatives and a favorable safety profile, Cabergoline has become a cornerstone therapy for managing prolactin-related disorders.
Cabergoline is a synthetic ergot-derived dopamine agonist that selectively activates D2 dopamine receptors in the pituitary gland. This action suppresses prolactin release, addressing the hormonal imbalance driving conditions like hyperprolactinemia.
Available as Cabergoline 0.5 mg tablets, this medication is marketed under brand names such as Dostinex. Each Cabergoline tablet delivers long-lasting effects, often requiring only twice-weekly dosing.
Cabergoline tablet uses include treating hyperprolactinemia, prolactinomas, and restoring fertility. Specifically, Cabergoline 0.5 mg tablet uses have been well-documented in clinical guidelines for managing elevated prolactin levels.
Primary Uses:
Symptoms Addressed:
Beyond its primary indication for hyperprolactinemia, cabergoline is sometimes prescribed off-label for Parkinson's disease management. The medication can help with movement difficulties, muscle control issues, and balance problems associated with this neurological condition.
Cabergoline functions as a potent dopamine D2 receptor agonist with a unique mechanism of action. The medication works by directly stimulating dopamine receptors on lactotroph cells in the pituitary gland, which are responsible for prolactin production. This stimulation effectively inhibits the secretion of the prolactin hormone from the pituitary gland.
The drug's long-acting properties make it particularly effective, with prolactin-lowering effects lasting up to 21 days after a single dose in some patients. Unlike other treatments, cabergoline's selective action on D2 receptors provides targeted therapy with minimal interference with other hormone systems.
Proper dosing of the cabergoline tablet is crucial for achieving optimal therapeutic outcomes while minimising side effects. The medication'should always be taken exactly as prescribed by your healthcare provider.
Typical Dosage Instructions:
| Age Group | Recommended Dosage |
|---|---|
| Adults | Start with 0.25 mg twice a week. The dose may be increased every 4 weeks based on prolactin levels, up to a maximum of 1 mg twice a week. |
| Children | Dosage and use must be determined by a healthcare professional. |
Get a second opinion from trusted experts and makeconfident, informed decisions.
Get Second OpinionIf you miss a dose of cabergoline, take it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Never take a double dose to make up for a missed one, as this can increase the risk of side effects.
Symptoms of Overdose:
What to Avoid: If overdose is suspected, contact poison control immediately or seek emergency medical attention. Do not attempt to treat overdose symptoms at home, and avoid driving or operating machinery if experiencing severe dizziness.
Note
| Feature | Cabergoline 0.25 mg | Cabergoline 0.5 mg |
|---|---|---|
| Strength | 0.25 mg | 0.5 mg |
| Common Use | Starting dose, dose titration | Maintenance, higher dose needs |
| Dose Flexibility | High (easy to adjust doses) | Lower (fixed double dose) |
| Pill Burden (for higher doses) | More tablets per week | Fewer tablets per week |
While cabergoline tab is generally well-tolerated, understanding potential side effects helps ensure safe usage. Most side effects are mild and tend to improve as your body adjusts to the medication.
Important: Contact your doctor immediately if you experience a persistent cough, chest pain, swelling in your extremities, or any signs of heart problems. Regular monitoring through echocardiograms may be recommended for individuals who use the device on a long-term basis.
Understanding who should avoid cabergoline and taking necessary precautions ensures safe treatment outcomes. Certain medical conditions require special consideration before starting this medication.
Cabergoline safety and effectiveness in pediatric patients have not been established. The medication is primarily prescribed for adults, and elderly patients may require closer monitoring due to increased sensitivity to side effects, particularly dizziness and blood pressure changes.
Cabergoline can interact with numerous medications, making it essential to inform your healthcare provider about all drugs and supplements you're taking. There are 156 known drug interactions with cabergoline.
Supplement and Herbal Interactions: Cabergoline may interact with various herbal products and supplements. St. John's Wort, for example, can affect how the medication is metabolised. Always discuss all supplements, vitamins, and herbal products with your healthcare provider before starting treatment.
Proper storage of cabergoline is essential for maintaining the medication's effectiveness and safety. Following storage guidelines helps ensure the drug remains potent throughout its shelf life.
Store cabergoline tablets at room temperature between 68°F and 77°F (20°C and 25°C). The medication can tolerate brief temperature excursions between 59°F and 86°F (15°C and 30°C) during transport, but should be returned to proper storage conditions promptly.
Improper storage can lead to medication degradation, reducing effectiveness and potentially creating harmful breakdown products. Exposure to excessive heat, moisture, or light can compromise the stability of the drug's chemical properties. Always check expiration dates and discard any medication that has been stored improperly or appears discoloured or damaged.
| Cabergoline | Bromocriptine |
|---|---|
| Formula: C26H37N5O2 Molecular Weight: 451.6 g/mol |
Formula: C32H40BrN5O5 Molecular Weight: 654.6 g/mol |
| Elimination half-life: 63-69 hours (estimated) | Elimination half-life: 12-14 hours |
| Cabergoline is an ergot derivative used to treat medical conditions associated with high levels of prolactin, such as prolactinomas or menstrual disorders. | Bromocriptine is an ergoline derivative used in treating hyperprolactinemia, Parkinson's disease, pituitary tumors, neuroleptic malignant syndrome, and as an adjunct in type 2 diabetes. |
Common side effects:
|
Common side effects:
|

Still have questions? Speak with our experts now!
040-68334455Cabergoline is used to treat hyperprolactinemia, a condition with high prolactin levels causing symptoms like infertility, sexual issues, and bone loss in non-breastfeeding women and men. It also treats prolactinomas and may be used for Parkinson’s disease.
Cabergoline starts lowering prolactin levels within 3 hours, with effects lasting 7–28 days in healthy volunteers and hyperprolactinemic patients, or 14–21 days in puerperal women.
Cabergoline reaches peak plasma levels within 2–3 hours after a single oral dose of 0.5–1.5 mg, but clinical effects may take longer to manifest.
Stopping Cabergoline suddenly can cause prolactin levels to remain high, potentially disrupting ovulation, menstrual cycles, and breast milk production in women, and causing sexual or reproductive issues in men.
Cabergoline is not primarily an antidepressant but has antidepressant-like properties by acting as a dopamine receptor agonist and enhancing brain-derived neurotrophic factor signaling.
Cabergoline is a dopamine receptor agonist used to treat hyperprolactinemia by reducing excess prolactin hormone levels in the blood, not a hormone drug itself.
Some research indicates that cabergoline administration can normalize androgen levels and boost menstrual irregularity in PCOS women. They conclude that cabergoline may play a useful role in treating menstrual abnormalities in PCOS patients by reducing prolactin secretion (30-31).
Cabergoline 0.5 mg tablet is used to treat hyperprolactinemia, a condition where excess prolactin causes hormonal imbalance. It is also effective in managing prolactinomas and restoring fertility.
Cabergoline 0.25 mg is typically used to initiate therapy, especially in sensitive individuals. The 0.5 mg dose is used for maintenance once tolerance and response are established.
When taken under medical supervision with periodic monitoring, cabergoline tablets can be safely used long-term, especially in treating chronic conditions like prolactinomas.
Disclaimer: The information provided is accurate and up-to-date to the best of our knowledge. However, it should not be considered a substitute for medical advice or consultation. We do not guarantee its completeness or accuracy. The absence of specific warnings does not mean a medicine is safe for all users. We are not responsible for any outcomes based on this information and strongly recommend consulting a doctor for any medical concerns or questions.